ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

LYEL Lyell Immunopharma Inc

2.36
-0.04 (-1.67%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Lyell Immunopharma Inc LYEL NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.04 -1.67% 2.36 09:00:00
始値 安値 高値 終値 前日終値
2.44 2.35 2.66 2.36 2.40
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/0606:30GLOBELyell Immunopharma Announces the Acceptance of Three..
2024/2/2906:07EDGAR2Form 8-K - Current report
2024/2/2906:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
2024/2/2706:05GLOBELyell Immunopharma Announces Participation in March Investor..
2024/2/1410:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1410:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1410:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:05GLOBELyell Immunopharma to Participate in 42nd Annual J.P. Morgan..
2023/11/2110:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2110:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2110:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2106:26EDGAR2Form 8-K - Current report
2023/11/1006:05GLOBELyell Immunopharma Receives FDA Orphan Drug Designation for..
2023/11/0806:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0806:08EDGAR2Form 8-K - Current report
2023/11/0806:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
2023/10/3122:00GLOBELyell Immunopharma Presentations at SITC Highlight New..
2023/9/2722:00GLOBELyell Immunopharma Announces the Acceptance of Six Abstracts..
2023/9/1122:16EDGAR2Form 8-K - Current report
2023/9/1121:00PRNUSCellares and Lyell to Evaluate Automated Manufacturing of..
2023/9/0105:05GLOBELyell Immunopharma to Participate in Upcoming Investor..
2023/8/0905:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0905:10EDGAR2Form 8-K - Current report
2023/8/0905:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
2023/7/0605:05GLOBELyell Immunopharma Appoints Matthew Lang as Chief Business..
2023/6/0805:05GLOBELyell Immunopharma to Participate in the Goldman Sachs..

最近閲覧した銘柄

Delayed Upgrade Clock